Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
3.290
-0.060 (-1.79%)
Apr 29, 2026, 9:34 AM EDT - Market open
Sana Biotechnology Market Cap
Sana Biotechnology has a market cap or net worth of $902.69 million as of April 29, 2026. Its market cap has increased by 162.19% in one year.
Market Cap
902.69M
Enterprise Value
867.03M
1-Year Change
162.19%
Ranking
Category
Stock Price
$3.29
Market Cap Chart
Since the IPO on February 4, 2021, Sana Biotechnology's market cap has decreased from $1.33B to $902.69M, a decrease of -31.87%. That is a compound annual growth rate of -7.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 894.46M | -17.49% |
| Dec 31, 2025 | 1.08B | 197.89% |
| Dec 31, 2024 | 363.93M | -54.75% |
| Dec 29, 2023 | 804.30M | 7.21% |
| Dec 30, 2022 | 750.19M | -73.52% |
| Dec 31, 2021 | 2.83B | 113.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xencor | 951.94M |
| Phathom Pharmaceuticals | 929.33M |
| Fortrea Holdings | 916.30M |
| Evommune | 914.15M |
| Janux Therapeutics | 913.08M |
| Maravai LifeSciences Holdings | 912.59M |
| Compass Therapeutics | 905.84M |
| LB Pharmaceuticals | 881.20M |